Full-Time

RN System Director Utilization Management

Utilization Management

Posted on 11/1/2025

Tufts Medicine

Tufts Medicine

501-1,000 employees

Integrated health system delivering connected care

Compensation Overview

$148k - $188.7k/yr

+ Base pay only

Remote in USA

Remote

Primarily remote; occasional travel to Tufts Medical Center, Melrose Wakefield Hospital, Lowell General Hospital, and Burlington, MA.

Category
Operations & Logistics (3)
, ,
Requirements
  • Bachelor of Science in Nursing (BSN).
  • RN Licensure.
  • Current certification in case/utilization management (ACM, CCM, CMAC)
  • Seven (7) years of UM/Case Management experience in an acute-care hospital or multi-hospital system, including two (2) years of supervisory experience.
Responsibilities
  • Serves as the UM first point of contact for Tufts Medicine.
  • Responsible for addressing complex issues, processes and root causes such as those stemming from an inability to achieve agreed upon metrics and targets.
  • Leads the development of policies to decrease variation in practices for Utilization Management.
  • Coordinates the setting of Utilization Management metrics and tracking across the markets.
  • Collaborates and meets regularly with Utilization Management, as well as corporate and revenue cycle leaders, to review metrics and discuss any operational issues. Coordinates Utilization Management meetings and deliverables.
  • Acts as Co-chair System UM Committee Meetings.
  • Responsible for resolving issues associated with performance in accordance with the process standards outlined.
  • Acts as the first point of contact for addressing any human resource related issues.
  • Responsible for facilitating and assigning representative(s) to participate in any UM initiative(s) at the corporate or local level as mutually agreed upon and approved by leadership.
  • Ensures adequate staff with the appropriate expertise to deliver timely information and to respond to facility, patient care team and payor inquiries regarding authorization number and authorized days, admission status and review, and concurrent reviews.
  • Responsible for daily operations, such as setting leadership behavior and human resources. Ensures ongoing collaboration with the Physician Advisor(s) and meet regularly with revenue cycle and finance leadership, attend various system-based revenue cycle, finance and operational meetings, as requested, and collaborate with site Case Management leadership.
  • Available to intervene in cases which fail to meet screening for admission or continued stay due to medically neuticessary care and/or if there is disagreement between UM RN and attending Physician in determining appropriate patient status.
  • Maintains ongoing collaborations and discussions with Clinical Documentation Integrity (CDI) and Coding leadership to review data and identify areas for clinical documentation improvement.
  • In the absence of a Physician Advisor, the hospital Chief Medical Officer (CMO) will be consulted.
Desired Qualifications
  • Master’s in Nursing
  • Fluent in CMS Two-Midnight, Inpatient-Only, Condition Codes 44 & W2, MOON/IMM, and payer-specific admission guidelines

Tufts Medicine is an integrated health system in Massachusetts that combines academic medical centers, community hospitals, a large home care network, and a clinically integrated physician network to deliver coordinated care. It includes Tufts Medical Center, Lowell General, MelroseWakefield, home health services, and a broad physician network, enabling care across settings. The system coordinates hospitals, doctors, and home care under one strategy to manage the patient journey, reduce fragmentation, and control costs while maintaining quality. Its goal is to deliver high-quality care at the lowest possible cost, expand access, and transform how people engage with healthcare.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Burlington, Massachusetts

Founded

2014

Simplify Jobs

Simplify's Take

What believers are saying

  • John Herman starts as President in September 2025, enhancing operations.
  • CEO chairs Massachusetts Health Association board for 71 hospitals.
  • Navvis scales risk-based contracts across Medicare, Medicaid, and commercial populations.

What critics are saying

  • Layoffs of 174 administrative staff erode efficiency and morale.
  • NENA merger causes physician exodus, weakening neuroscience against Mass General Brigham.
  • Navvis partnership fails, exposing unprofitable Medicare and Medicaid contracts.

What makes Tufts Medicine unique

  • Tufts Medicine partners exclusively with Navvis to accelerate value-based care.
  • Acquires New England Neurological Associates for neuroscience expansion.
  • Appoints John Herman as Tufts Medical Center President with 30 years expertise.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401(k) Company Match

403(b) Retirement Plan

Tuition Reimbursement

Company News

Aalborg University
Dec 10th, 2025
Persistent inequity in survival after atrial fibrillation

Persistent inequity in survival after atrial fibrillation. Atrial fibrillation, also known as AF or Afib, is one of the most common cardiovascular diseases. In fact, one in three individuals can expect to be diagnosed by the condition, which increases the risk of serious complications such as heart failure and stroke. Despite significant advances in the treatment of atrial fibrillation, a new Danish study from Aalborg University shows that social inequities in survival have remained virtually unchanged over the past 20 years. The article has just been published in the internationally recognized journal The Lancet Public Health in collaboration with the University of Liverpool, Tufts Medical Center in Boston, and Boston University. The study is based on nationwide Danish registry data from more than 380,000 patients diagnosed with atrial fibrillation between 2000 and 2022 and documents inequities in income, education, and social relationships still have a major impact on life expectancy after diagnosis. Individuals diagnosed with AF who have a low income live on average 2.5 years shorter than those with high income. Low educational level results in a loss of 1.8 years of life, while living alone costs about 1.6 years. "Advances in the management and treatment of atrial fibrillation have improved survival for everyone but have not closed the gap between social groups. This is clearly a problem in a tax-funded universal healthcare system with formally equal access to treatment for all - especially when we know how much prevention can actually matter," says the study's lead author, Nicklas Vinter, MD, PhD, and postdoctoral researcher at the Danish Center for Health Services Research at Aalborg University. He also points out that the global incidence of atrial fibrillation is rising, making the results relevant far beyond Denmark's borders. This is clearly a problem in a tax-funded universal healthcare system with formally equal access to treatment for all - especially when Adsl Aau know how much prevention can actually matter. Social and structural barriers must be addressed. According to Nicklas Vinter, the causes of inequity are not only linked to medical treatment but also to social and behavioral factors. For some patients, treatment guidelines can be difficult to understand and translate into concrete action, and many lack a social network that can provide practical support in everyday life. Therefore, the researchers behind the study propose a new tool, FAIR-PRO-AF, which can help decision-makers and researchers across sectors systematically reduce inequity and create continuous improvements. The tool is designed as a circular work cycle: first, the social factors associated with survival are mapped. Next, the barriers that hinder equity in access, quality, and effectiveness of treatment are identified. In the third step, concrete initiatives are prioritized and implemented, and finally, the effect is evaluated before the cycle moves on to the next round. "The social and structural barriers that limit patients' access to knowledge, resources, and support must be addressed if we want to improve prognoses for all. This requires a broader effort where the healthcare system collaborates with social and political actors," says Nicklas Vinter. Facts: Atrial fibrillation * Atrial fibrillation is the most common cardiac arrhythmia. * Symptoms of atrial fibrillation include shortness of breath, palpitations, and chest pain. * The condition is associated with increased mortality - on average, a patient with atrial fibrillation loses about two years of expected lifespan compared to individuals without the diagnosis. * In Denmark, more than 170,000 people live with the condition, * Each year, more than 20,000 Danes receive the new diagnosis. Read the scientific article: Temporal trends in associations between social drivers and life-years lost in newly diagnosed atrial fibrillation in Denmark, 2000 - 22: a nationwide cohort study Published in The Lancet Public Health, December 2025. Authors: Nicklas Vinter, Søren Paaske Johnsen, Gregory Yoke Hong Lip, Ludovic Trinquart, Lars Frost and Emelia J. Benjamin.

Central Penn Business Journal
Jun 30th, 2025
Former CEO of Penn Medicine LGH named president of Tufts Medical Center

Former Penn Medicine Lancaster General Health Chief Executive Officer John Herman has been appointed as the new President of Tufts Medical Center in Boston, the health system's academic medical center.

The Indian EYE
May 30th, 2025
Dr. Soma Sengupta appointed Tufts University's New Chair of the Department of Neurology

Dr. Soma Sengupta, MD, PhD, MBA, FRCP, FANA, FAAN will join Tufts Medical Center (Tufts MC) as Chair of the Department of Neurology and Neurologist-in-Chief in September 2025.

The Boston Globe
Mar 20th, 2025
Lawrence General, Holy Family hospitals appoint new interim CEO

After a challenging year for Lawrence General Hospital and Holy Family Hospital, former Tufts Medical executive Diana L. Richardson will take over as interim president and CEO next month, the hospital system announced Thursday.

Medical Device Network
Sep 26th, 2024
CereVasc's endovascular device may offer gene therapy delivery pathway to brain

US-based CereVasc collaborated with researchers from the UMass Chan Medical School and Tufts Medical Center for the study.

INACTIVE